Kelly Bowen

Company: KSQ Therapeutics, Inc.

Job title: scientist

Seminars:

Panel Discussion: Contrasting Characterization Strategies Across Cell Therapy Modalities to Understand the Diversity of Cell Therapy Platforms 11:55 am

Explore the unique challenges and considerations in characterizing immunotherapy products, including antigen specificity, T-cell functionality, and cytokine secretion profiles. Compare and contrast characterization approaches between autologous and allogeneic cell therapies, examining donor variability, immune compatibility testing, and scalability considerations. Explore the complexities of characterizing gene therapy products, including the need for precise vector identity, potency,…Read more

day: Track A - Cell Based Assay (Day Two - Morning)

Enhancing Potency Assay Strategy for CGT: Unlocking Precision & Reliability for Regulatory Approval 10:00 am

Delve into the new potency assurance guidance and understand how to align potency methods with regulatory requirements to meet expectations and ensure compliance. Explore effective strategies to mitigate risks to a product’s potency Discover how collaborative initiatives streamline compliance efforts and facilitate the adoption of best practices, particularly in addressing the complexities of new regulatory…Read more

day: Conference Day One